Molex opens ‘State-of-the-Art Campus’ in Poland

1 min read

Molex has announced a major expansion of its global manufacturing footprint with the opening of a new campus in Katowice, Poland.

The facility’s initial 23,000 square-meter manufacturing space will serve as a strategic central location to help in the delivery of advanced medical devices for Phillips-Medisize, a Molex company, as well as electric vehicle and electrification solutions for Molex customers.

According to Molex, future expansion of up to 85,000 square meters is built into its growth plans for the facility, further increasing Molex’s presence in Poland, adding to existing sites in Rokitki and Sulęcin.

“The Katowice campus will expand our European footprint, providing our pharmaceutical, diagnostic and medtech customers with new capabilities and the expert support they need to bring innovative new products to market,” said Paul Chaffin, Phillips-Medisize SVP and president of Molex Medical and Pharma Solutions.

Molex has so far invested $110 million in these facilities that will initially support Phillips-Medisize with production of pharmaceutical, medical and diagnostic devices. The site will have state-of-the-art capabilities, including advanced medical device assembly, packaging, drug handling and injection moulding.

Additionally, the campus will manufacture interconnect battery solutions for electric vehicles and high-power busbar solutions for Molex’s electrification business.

Katowice will complement Phillips-Medisize’s existing operations at six European manufacturing sites in Donegal and Sligo, Ireland; Struer, Denmark; Trhove Sviny, Czech Republic; and two locations in Kontiolahti, Finland.

The large pool of skilled manufacturing and engineering resources in the Katowice area was a major factor influencing selection of the site location, according to Molex. At planned capacity, the first facilities within the campus will employ approximately 350 employees, including highly skilled production operators, design engineers and quality specialists.

Combining high technology expertise and skilled labour means that both Phillips-Medisize medical customers and Molex automotive and electrification customers now have access to the company’s expert capabilities, high-quality services and support in a location that enables speed-to-market and superior quality in product delivery.

The campus will be the first site for both Molex and Phillips-Medisize to hold a LEED Gold certification. ISO 13485 certification is pending construction completion, with additional certifications and registrations to follow, offering more localized value to those customers who require this exacting manufacturing quality.